Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial
scientific article published on 17 November 2017
Author/s
author: Angelo Di Leo, Sibylle Loibl, Giuseppe Viale, Patrick Neven, Harold J. Burstein, Aron Goldhirsch, Meredith M Regan, Karin Ribi, Marco Colleoni, Thomas Ruhstaller, Edda Simoncini, Katsumasa Kuroi, Christian Marth
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.